INS and cirrhosis of liver: Given their fragility and frequent admission, it is recommended to treat patients with decompensated liver cirrhosis with basal long-acting insulin analogs with or without rapid-acting insulin analogs, carefully titrating the insulin doses and closely monitoring the blood glucose levels (Figure 1).